Medicare Enrolled
Dr. Thomas White, M.D.
Pain Medicine · Shenandoah, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. White from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. White? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. White
Dr. Thomas White is a pain medicine in Shenandoah, TX, with 12 years in practice. Based on federal Medicare data, Dr. White performed 7,805 Medicare services across 1,716 unique beneficiaries.
Between the years covered by Open Payments, Dr. White received a total of $115,116 from 54 pharmaceutical and/or device companies across 560 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pain medicine. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. White is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 12 years in practice▲ Top 11% volume in TX$ $115,116 industry payments
Medicare Practice Summary
Medicare Utilization ↗7,805
Medicare services
Top 11% in TX for pain medicine
1,716
Unique beneficiaries
$70
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~650 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) | 1,325 | $81 | $271 |
| Testing for presence of drug, read by direct observation | 1,190 | $12 | $60 |
| Steroid injection (triamcinolone) | 1,142 | $1 | $5 |
| Chronic pain management and treatment, monthly bundle including, diagnosis; assessment and monitoring; administration of a validated pain rating scale or tool; the development, implementation, revision, and/or maintenance of a person-centered care plan tha | 1,066 | $52 | $205 |
| Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 766 | $191 | $398 |
| Remote therapeutic monitoring treatment management services by physician or other qualified health care professional, first 20 minutes per calendar month | 336 | $33 | $153 |
| Device supply with scheduled recording and transmission for remote monitoring of musculoskeletal system, per 30 days | 310 | $33 | $130 |
| Contrast dye for imaging, lower concentration | 236 | $0 | $22 |
| Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 234 | $240 | $495 |
| Remote therapeutic monitoring treatment management services by physician or other qualified health care professional, each additional 20 minutes per calendar month | 217 | $26 | $126 |
| Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 167 | $110 | $229 |
| Complex chronic care management services for two or more chronic conditions, each additional 60 minutes of clinical staff time directed by health care professional, per calendar month | 72 | $48 | $100 |
| Complex chronic care management services for two or more chronic conditions, first 60 minutes of clinical staff time directed by health care professional, per calendar month | 71 | $89 | $200 |
| Each additional 15 minutes of chronic pain management and treatment by a physician or other qualified health care professional, per calendar month. (list separately in addition to code for g3002. when using g3003, 15 minutes must be met or exceeded.) | 60 | $19 | $75 |
| Injection, ketorolac tromethamine, per 15 mg | 58 | $0 | $2 |
| New patient office visit (45-59 min) | 54 | $98 | $350 |
| Insertion of spinal neurostimulator electrode array through skin | 51 | $1,148 | $4,894 |
| Fluoroscopic guidance for needle placement | 42 | $78 | $335 |
| Joint injection, major joint | 38 | $35 | $195 |
| Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 35 | $153 | $314 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 34 | $159 | $842 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | 32 | $83 | $842 |
| Set-up and patient education for remote monitoring of therapy | 29 | $13 | $50 |
| Psychiatric diagnostic evaluation | 27 | $114 | $450 |
| Office visit, established patient (20-29 min) | 26 | $60 | $190 |
| Insertion of spinal neurostimulator generator or receiver | 22 | $129 | $1,140 |
| Injection of upper or middle spine facet joint using imaging guidance, single level | 22 | $144 | $979 |
| Injection of upper or middle spine facet joint using imaging guidance, second level | 22 | $87 | $505 |
| Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | 21 | $130 | $656 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 20 | $202 | $931 |
| Electronic analysis of implanted neurostimulator generator with complex spinal cord or peripheral nerve stimulator programming | 20 | $37 | $125 |
| Destruction of upper or middle spinal facet joint nerves using imaging guidance, single facet joint | 16 | $174 | $2,438 |
| Destruction of upper or middle spinal facet joint nerves using imaging guidance, each additional facet joint | 16 | $61 | $934 |
| Injection of anesthetic agent and/or steroid into knee nerve branch using imaging guidance | 14 | $138 | $450 |
| Office visit, established patient, complex (40-54 min) | 14 | $114 | $280 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$115,116
Total received (2018-2024)
Avg $16,445/year across 7 years
Top 3% in TX for pain medicine
54
Companies
560
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$79,827 (69.3%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$26,560 (23.1%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,728 (7.6%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$52,089
2023$48,730
2022$8,070
2021$2,930
2020$1,600
2019$1,572
2018$125
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Medtronic, Inc.
$81,161
Nevro Corp.
$25,669
Abbott Laboratories
$2,264
Vertiflex, Inc.
$1,381
Boston Scientific Corporation
$770
BOSTON SCIENTIFIC CORPORATION
$389
ABBVIE INC.
$348
Relievant Medsystems, Inc.
$282
AbbVie Inc.
$251
Indivior Inc.
$190
Vertos Medical, Inc.
$169
Spinal Simplicity, LLC
$150
Medtronic USA, Inc.
$142
Allergan, Inc.
$132
GRT US Holding, Inc.
$121
Novartis Pharmaceuticals Corporation
$118
PFIZER INC.
$113
SCILEX PHARMACEUTICALS INC.
$93
Biohaven Pharmaceuticals, Inc.
$89
Arbor Pharmaceuticals, Inc.
$89
Almatica Pharma LLC
$89
MML US, Inc.
$86
Azurity Pharmaceuticals, Inc.
$82
Biohaven Pharmaceutical Holding Company Ltd.
$76
Amgen Inc.
$75
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$65
Scilex Pharmaceuticals Inc.
$56
BIOTRONIK NRO, Inc.
$53
Merz Pharmaceuticals, LLC
$43
ARBOR PHARMACEUTICALS, INC.
$34
IBSA Pharma Inc.
$33
US WorldMeds, LLC
$33
BioDelivery Sciences International, Inc.
$31
Kowa Pharmaceuticals America, Inc.
$31
Nalu Medical, Inc.
$30
BIODELIVERY SCIENCES INTERNATIONAL, INC.
$27
SPR Therapeutics, Inc
$27
Averitas Pharma Inc.
$26
VERTEX PHARMACEUTICALS INCORPORATED
$25
FORTE BIO-PHARMA LLC
$24
TerSera Therapeutics LLC
$23
Bioventus LLC
$23
PAINTEQ LLC
$22
Curonix LLC
$19
IMPEL PHARMACEUTICALS INC.
$19
RedHill Biopharma Inc.
$18
Lilly USA, LLC
$18
UPSHER-SMITH LABORATORIES LLC
$17
Saluda Medical Americas, Inc.
$17
ITI, Inc.
$17
Foundation Fusion Solutions, LLC
$16
SUN PHARMACEUTICAL INDUSTRIES INC.
$14
Horizon Therapeutics plc
$14
Zyla Life Sciences, Inc.
$13
Top 3 companies account for 94.8% of total payments
Associated products mentioned in payments ›
ADAPTIVESTIM · AIMOVIG · AXIUM · Aimovig · Axium INS DRG IPG · BELBUCA · BOTOX · BUNAVAIL · CAPLYTA · COMIRNATY · Durolane · EMGALITY · ETERNA · Evoke SCS · GENERAL PAIN MANAGEMENT · GENERAL - PAIN MANAGEMENT · GRALISE · HORIZANT · Horizant · INCEPTIV · INTELLIS · INTELLIS ADAPTIVESTIM · Intracept · KAPSPARGO · KYPHON EXPRESS II KYPHOPAK TRAY · LICART · Licart · Lucemyra · Lucemyra/Lofexidine · Minuteman · Movantik · NAPRELAN · NURTEC ODT · Nalu Neurostimulation System · Neuromodulation Dspsbls and Accs · OCTRODE · Octrode SCS Leads · PAINTEQ · PAXLOVID · PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A · PROCLAIM · PROLATE · Prialt · Proclaim Family of SCS IPGs · Proclaim IPG · Prospera · QULIPTA · QUTENZA · Qutenza · RELISTOR · RESTORE · ReActiv8 · SPECIFY SURESCAN MRI 5-6-5 · SPRINT PNS System · SPRIX · SUBLOCADE · SUPERION · SYNCHROMEDII · Seglentis · Senza · Senza Spinal Cord Stimulation System · Superion ISS · Superion Indirect Decompression System · TOSYMRA · Trudhesa · UBRELVY · V-LOC 180 · VANTA ADAPTIVESTIM · VECTRIS · VECTRIS SURESCAN · VERTIFLEX SUPERION · VIMOVO · Vyrsa V1 · Xeomin · ZTLido · mild Device Kit
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (69%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in pain medicine and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 3% for pain medicine in TX.
Equivalent to $1,475 per 100 Medicare services performed
Geographic Context
Pain Medicines within 10 mi
5
Per 100K population
0.8
County median income
$97,266
Nearest hospital
ST LUKE'S THE WOODLANDS HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. White is a clinical cardiology specialist, with above-average Medicare volume (top 11% in TX), and high industry engagement (speaking/promotional, top 3%).
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. White experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. White performed 1,325 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. White receive payments from pharmaceutical companies?
Yes. Dr. White received a total of $115,116 from 54 companies across 560 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. White's costs compare to other pain medicines in Shenandoah?
Dr. White's average Medicare payment per service is $70. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. White) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Pain Medicines in Shenandoah
Browse pain medicines in Shenandoah ranked by procedure volume and transparency data.
Highest volume
Top Pain Medicines in TX
Pain Medicines ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pain Medicines in TX
Which TX pain medicines receive the most from drug and device companies.
By company
Medtronic, Inc. Payments to Doctors
See all physicians who received payments from Medtronic, Inc..
By company
Nevro Corp. Payments to Doctors
See all physicians who received payments from Nevro Corp..
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology